Is Impact Biomedical Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Impact Biomedical Inc (IBO) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Impact Biomedical Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Impact Biomedical Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Impact Biomedical Inc?

Muslim investors may consider investing in Impact Biomedical Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Impact Biomedical Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Impact Biomedical Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Impact Biomedical Inc updated?

The Shariah compliance status of Impact Biomedical Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Impact Biomedical Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Impact Biomedical Inc?

You can check the latest Shariah compliance status of Impact Biomedical Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

IBO Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 12, 2026

Report Source: 2025 Annual Report

Impact Biomedical Inc. Stock Analysis IBO

United States Health Care Micro Cap Report: 2025 Annual

Impact BioMedical, Inc. is a holding company, which engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. The company is headquartered in Houston, Texas and currently employs 2 full-time employees. The company went IPO on 2024-09-16. The company discovers, confirms, and patents science and technologies, which can be developed into new offerings in biopharmaceuticals and consumer healthcare and wellness in collaboration with external partners through research, licensing, co-development, joint ventures, and other relationships. The company has several technologies that are in continuing development, which include Linebacker, Laetose, Functional Fragrance Formulation (3F), Equivir/Equivir G, and Celios. Linebacker is a platform of small molecule electrophilically enhanced polyphenol compounds with potential application in oncology (solid tumors), inflammatory disorders, and neurology. Laetose technology is derived from a combination of multiple sugars independently with myo-inositol. 3F is a suite of organic functional fragrances. Celios is an air purification technology. The company also evaluates additional technologies.

Key Statistics of Impact Biomedical Inc (IBO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.53$0.57

Today's Open

$0.57

Volume

45.73K

P/E Ratio (TTM)

52 Week Range

$0.36$1.95

Market Cap

67.27M

Avg. Volume

73.50K

Dividend Yield

Financial Metrics & Statements of Impact Biomedical Inc (IBO)

FAQ's for Impact Biomedical Inc (IBO)

According to Musaffa’s Shariah screening methodology, Impact Biomedical Inc (IBO) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.